Neuroprotection in experimental stroke with targeted neurotrophins. - Wikidata - awgldk - TriplyDB

Neuroprotection in experimental stroke with targeted neurotrophins.

Neuroprotection in experimental stroke with targeted neurotrophins.

http://www.wikidata.org/entity/Q33569623

about

Neuroprotection for ischemic stroke: past, present and future Potential therapeutic effects of neurotrophins for acute and chronic neurological diseases Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders Derivation of injury-responsive dendritic cells for acute brain targeting and therapeutic protein delivery in the stroke-injured rat Alpha-linolenic acid: an omega-3 fatty acid with neuroprotective properties-ready for use in the stroke clinic?Progress and problems in the application of focused ultrasound for blood-brain barrier disruption.Microglial involvement in neuroplastic changes following focal brain ischemia in rats.Non-Coding RNAs as Potential Neuroprotectants against Ischemic Brain Injury.Targeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protection Cell signaling pathways in the mechanisms of neuroprotection afforded by bergamot essential oil against NMDA-induced cell death in vitro.A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression.Protein changes in CSF of HIV-infected patients: evidence for loss of neuroprotection.MAPT isoforms: differential transcriptional profiles related to 3R and 4R splice variants Fear extinction and BDNF: translating animal models of PTSD to the clinic.Growth factors and stroke.Enviromimetics: exploring gene environment interactions to identify therapeutic targets for brain disorders.Rac1 is a critical mediator of endothelium-derived neurotrophic activity.Beta-amyloid toxicity and reversal in embryonic rat septal neurons.Mimetics of brain-derived neurotrophic factor loops 1 and 4 are active in a model of ischemic stroke in rats Mechanisms and targets for angiogenic therapy after stroke.Fibroblast growth factors in schizophrenia.Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease.Beta-amyloid toxicity in embryonic rat astrocytes.Fibroblast growth factors in neurodevelopment and psychopathology.Targeted delivery of nano-therapeutics for major disorders of the central nervous system.From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF)Growth factor conjugation: strategies and applications.Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.Phytochemicals in Ischemic Stroke.Pharmacogenetics and Pharmacotherapy of Military Personnel Suffering from Post-traumatic Stress Disorder.Transfection of primary brain capillary endothelial cells for protein synthesis and secretion of recombinant erythropoietin: a strategy to enable protein delivery to the brain.A Novel Cell Therapy Method for Recovering after Brain Stroke in Rats.Investigation of the metabolism of substance P at the blood-brain barrier using LC-MS/MS.Regulation of GDF-15, a distant TGF-β superfamily member, in a mouse model of cerebral ischemia Lipoic acid and bone marrow derived cells therapy induce angiogenesis and cell proliferation after focal brain injury.Intense training overcomes effects of the Val66Met BDNF polymorphism on short-term plasticity.Targeting the reconsolidation of extinction memories: a novel potential strategy to treat anxiety disorders.Neuroprotective effect of GK-2, a dipeptide mimetic of nerve growth factor, during experimental focal ischemia in middle cerebral artery basin.Activation of expression of brain-derived neurotrophic factor at the site of implantation of allogenic and xenogenic neural stem (progenitor) cells in rats with ischemic cortical stroke.bFGF plays a neuroprotective role by suppressing excessive autophagy and apoptosis after transient global cerebral ischemia in rats.

P2860

Q24645185-E5F08A80-F119-4A15-928A-018A78DCE3BE Q26827281-A1212191-69D4-4309-9B69-BC7D310290EC Q27006437-52CC1771-4F67-4AF7-BAB1-0CF72C53D612 Q27324122-C0B46E0A-583F-4B84-9B1D-FB7D5C3BAFBE Q28085176-4A9FE688-DBFE-4D73-B5C7-CC49049830EE Q30487878-28D8BC52-BF85-48F3-83DA-FE2133FFF8C4 Q30940972-FFD24FFB-04F8-4611-A905-95B01D23106C Q33772089-7DC4CF13-3395-4D0C-B57D-34ECB0CE0D09 Q34088803-566F031F-6076-41F1-9E2D-398181B001EA Q34578270-7992D8A5-589B-42F5-A6FD-D1F9F890B672 Q34815480-1C7423C7-4DFA-44CF-8D00-726FC2BD69D3 Q35195927-8BDDEC5A-E23E-4E92-B743-E3B05DAF9187 Q35878417-BF93D25A-CA75-4D46-A2E9-78B0BA33DB53 Q36074354-7A698A80-0AD7-4DF6-BF5A-D9252889B69C Q36608807-5FD48B3E-CCBD-4371-9006-E5DE872354D7 Q36871981-1C0B8267-9121-4075-B4B2-AD6D8B0CF97A Q37157708-DC51A6CD-FCA0-4BE6-B2FC-C7A56773946B Q37362146-221ECAD7-BC2C-40B1-A906-E5C59A537157 Q37397855-0BCB0FA8-3313-44A7-9836-56ACCEEA6055 Q37442498-A739C127-AF13-42AB-AB8D-05E29508C9D1 Q37476441-B981E50B-70C8-49C8-A87C-01A45EBB3D9F Q37584887-837C7644-DF3B-463D-B9C9-7FA44ABF0972 Q37592514-D873DC7E-8F0A-4C9B-8070-0AD24BC3C6A0 Q38076267-A899AC23-76FD-449B-97BE-94A3DD53BC6E Q38116765-D434FD5A-8981-4B9B-9CDC-9372F7167A08 Q38168376-66E7CADD-D005-494A-9024-E85C5F84E092 Q38204731-FC13F51A-D14E-4925-88DF-8601FC6087A4 Q38587566-B3FDEC27-6D4E-4577-A6C6-0D22C94BC043 Q38837831-69B8AD01-2FB1-438E-AADB-D40B245C8B3D Q39005149-0A960145-9547-4FBB-8136-FE00FCA61CF2 Q40292313-72B881B7-1B07-4C99-9BD5-08FF863484A0 Q41826915-6E56D747-288F-4CC0-86A4-DDB92586DFB1 Q41864443-254B93DD-E52D-4F36-87D0-69F161E56A2C Q42587600-FA347F9E-D52A-4CBF-B6F4-F5675ED28F81 Q45036156-64446D48-DF49-4C9F-B77A-6DD9E7EA3476 Q46335749-75CBDEDE-8406-444F-B390-A1E55020B3C2 Q47646548-1FB7EB99-49B7-472D-B57E-0247201AD8E9 Q48591169-003D07CF-C9A8-450B-AD75-208C5578E4AA Q48696877-ED3FC9DA-4A79-4EB5-992F-F934BEFE205F Q50130030-402DA6E5-AEE7-490D-9696-EE23F95CB022

P2860

Neuroprotection in experimental stroke with targeted neurotrophins.

http://www.wikidata.org/entity/Q33569623

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Neuroprotection in experimental stroke with targeted neurotrophins.

@ast

Neuroprotection in experimental stroke with targeted neurotrophins.

@en

Neuroprotection in experimental stroke with targeted neurotrophins.

@nl

type

label

Neuroprotection in experimental stroke with targeted neurotrophins.

@ast

Neuroprotection in experimental stroke with targeted neurotrophins.

@en

Neuroprotection in experimental stroke with targeted neurotrophins.

@nl

prefLabel

Neuroprotection in experimental stroke with targeted neurotrophins.

@ast

Neuroprotection in experimental stroke with targeted neurotrophins.

@en

Neuroprotection in experimental stroke with targeted neurotrophins.

@nl

P1433

Q33569623-51F37D56-C724-4D44-8949-79E376B2C08D

P1476

Q33569623-8B052631-8369-4D45-A969-18BB9D01A4D0

P2093

Q33569623-3DBA6767-4519-4FE1-B171-C1B9B9471B40

P2860

Q33569623-00A725BD-73FB-4469-A8CE-BE67D9C30A0E

Q33569623-056FCA1F-7E52-4626-8A6B-70980E4E6CB4

Q33569623-05F1688F-F40C-465E-B620-BE4FFA31C1ED

Q33569623-08843494-2485-41DC-BB2B-00BBD9C7DE75

Q33569623-105D7FBC-4B24-468A-B58F-954825B2417E

Q33569623-13DC6B8F-F481-43D4-8306-440D5C44843D

Q33569623-16173511-A474-4F80-A4DB-554B43F7DCAC

Q33569623-19F286B3-4C44-48B2-B7C2-B9E6B760E963

Q33569623-1CA87224-A77A-4D3A-95BC-252043F5ECCE

Q33569623-2674144A-B2AE-4324-B660-758F2C556E7D

P304

Q33569623-E6151CE0-17F4-41E9-A3FB-572AE9F91F27

P31

Q33569623-B1B7F5E3-0593-4498-B0AE-FE25CE465584

P356

Q33569623-AEDA55F0-C92C-4ACA-A499-6687E77FBF89

P433

Q33569623-738939D8-FD0F-4138-95EA-654FDB4554C6

P478

Q33569623-B416486A-41D9-443F-A371-775EB5B6D5C6

P577

Q33569623-934A104C-47E1-479F-B80E-43D5658354B7

P5875

Q33569623-5548AFBC-CEAC-4DE1-A9A4-EA80AA1F3CF4

P698

Q33569623-07AC2523-27CF-4A8F-A592-AFAD54FC1D37

P932

Q33569623-8D2ABA8D-9C2D-4C2F-A204-2F54F2357B2E

P356

NEURORX.2.1.120

P1433

P1476

Neuroprotection in experimental stroke with targeted neurotrophins.

@en

P2093

Dafang Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Stroke, dementia, and drug delivery

New perspectives on the pharmacotherapy of ischemic stroke

Neuroprotection for ischemic stroke

Dual antiplatelet therapy for prevention of recurrent ischemic events

Structural and functional diversity in the FGF receptor multigene family

Tissue plasminogen activator for acute ischemic stroke

Potential usefulness of basic fibroblast growth factor as a treatment for stroke.

Thrombolysis in acute ischemic stroke: controlled trials and clinical experience.

Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Transport of human recombinant brain-derived neurotrophic factor (BDNF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery.

P304

120-128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1602/NEURORX.2.1.120

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8016262

http://www.w3.org/2001/XMLSchema#string

P698

15717063

http://www.w3.org/2001/XMLSchema#string

P932

539332

http://www.w3.org/2001/XMLSchema#string